R Brett McQueen
Biographic Data
| ID | 5868611 |
|---|---|
| NAME | R Brett McQueen |
| GIVEN NAMES | R Brett |
| FAMILY NAME | McQueen |
| SIGNATURE | MCQUEEN R B |
| AFFILIATIONS | University of Colorado Anschutz Medical Campus |
| ORCID | 0000-0002-4302-2678 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1939 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 0 |
Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine
The Second Panel on Cost-Effectiveness in Health and Medicine convened on December 7, 2016 at the National Academy of Medicine to disseminate their recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses (CEAs). Following its summary, panel proceedings included lengthy discussions including the field’s struggle to disseminate findings efficiently through peer-reviewed literature to target audiences. Wit…
Finding Resolution for the Responsible Transparency of Economic Models in Health and Medicine
The Second Panel on Cost-Effectiveness in Health and Medicine recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses has a number of questions unanswered with respect to the implementation of transparent, open source code interface for economic models. The possibility of making economic model source code could be positive and progressive for the field; however, several unintended consequences of this s…
Economic Differences in Direct and Indirect Costs Between People With Epilepsy and Without Epilepsy
OBJECTIVE: To provide generalizable estimates of economic burden in epilepsy and nonepilepsy populations and a comprehensive accounting for employment-based lost productivity associated with epilepsy in current US health care systems as compared with other chronic diseases. RESEARCH DESIGN: We use the nationally representative data source (Medical Expenditure Panel Survey) from 1998 to 2009 to create a retrospective cohort of people diagnosed wit…
Canada's Unemployment Problem . L. Richter
No prominent works on this page.
Canada's Unemployment Problem . L. Richter
Economic Differences in Direct and Indirect Costs Between People With Epilepsy and Without Epilepsy
OBJECTIVE: To provide generalizable estimates of economic burden in epilepsy and nonepilepsy populations and a comprehensive accounting for employment-based lost productivity associated with epilepsy in current US health care systems as compared with other chronic diseases. RESEARCH DESIGN: We use the nationally representative data source (Medical Expenditure Panel Survey) from 1998 to 2009 to create a retrospective cohort of people diagnosed wit…
Can Economic Model Transparency Improve Provider Interpretation of Cost-effectiveness Analysis? Evaluating Tradeoffs Presented by the Second Panel on Cost-effectiveness in Health and Medicine
The Second Panel on Cost-Effectiveness in Health and Medicine convened on December 7, 2016 at the National Academy of Medicine to disseminate their recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses (CEAs). Following its summary, panel proceedings included lengthy discussions including the field’s struggle to disseminate findings efficiently through peer-reviewed literature to target audiences. Wit…
Finding Resolution for the Responsible Transparency of Economic Models in Health and Medicine
The Second Panel on Cost-Effectiveness in Health and Medicine recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses has a number of questions unanswered with respect to the implementation of transparent, open source code interface for economic models. The possibility of making economic model source code could be positive and progressive for the field; however, several unintended consequences of this s…
Computer Science (3 works) · Political science (3 works) · Business (2 works) · Economics (2 works) · Health care (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Healthcare cost, quality, practices (2 works) · Law (2 works) · Medicine (2 works) · Pharmaceutical Economics and Policy (2 works)